William D. Travis
#113,023
Most Influential Person Across History
Researcher
William D. Travis's AcademicInfluence.com Rankings
William D. Travisengineering Degrees
Engineering
#2543
Historical Rank
Electrical Engineering
#289
Historical Rank
William D. Traviscomputer-science Degrees
Computer Science
#2850
Historical Rank
Computational Linguistics
#52
Historical Rank
Machine Learning
#197
Historical Rank
Artificial Intelligence
#339
Historical Rank
Download Badge
Engineering Computer Science
William D. Travis's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is William D. Travis Influential?
(Suggest an Edit or Addition)William D. Travis's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive molecular profiling of lung adenocarcinoma (2014) (4095)
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors (2002) (3524)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma (2011) (3193)
- Comprehensive genomic characterization of squamous cell lung cancers (2012) (2998)
- The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. (2015) (2865)
- An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. (2013) (2746)
- Wegener granulomatosis: an analysis of 158 patients. (1992) (2702)
- Somatic mutations affect key pathways in lung adenocarcinoma (2008) (2640)
- The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer (2016) (2632)
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline (2018) (2039)
- Pathology and genetics of tumours of the lung , pleura, thymus and heart (2004) (1844)
- WHO classification of tumours of the lung, pleura, thymus and heart (2015) (1690)
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing (2012) (1620)
- Comprehensive genomic profiles of small cell lung cancer (2015) (1397)
- Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017. (2017) (1337)
- Histological Typing of Lung and Pleural Tumours (1999) (1295)
- A Report of Three Cases (1986) (1205)
- Characterizing the cancer genome in lung adenocarcinoma (2007) (1122)
- Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study (2008) (1063)
- The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2007) (950)
- Neuroendocrine Tumors of the Lung With Proposed Criteria for Large‐Cell Neuroendocrine Carcinoma: An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases (1991) (841)
- Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases (2011) (833)
- Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. (2015) (802)
- Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. (1998) (768)
- The 2004 World Health Organization classification of lung tumors. (2005) (683)
- American Cancer Society lung cancer screening guidelines (2013) (638)
- Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas. (2007) (636)
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal (2018) (636)
- Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. (2017) (629)
- Histopathologic variability in usual and nonspecific interstitial pneumonias. (2001) (622)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. (2011) (600)
- Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? (2004) (582)
- Pathology of lung cancer. (2002) (574)
- The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. (2012) (535)
- Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. (2000) (517)
- Radiological versus histological diagnosis in UIP and NSIP: survival implications (2003) (513)
- Endothelins, peptides with potent vasoactive properties, are produced by human macrophages (1990) (491)
- Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. (2003) (487)
- Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. (2008) (485)
- CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. (1989) (481)
- Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. (2003) (481)
- New pathologic classification of lung cancer: relevance for clinical practice and clinical trials. (2013) (479)
- The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part‐Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer (2016) (443)
- Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections. (2010) (424)
- Diffuse lung disease in young children: application of a novel classification scheme. (2007) (423)
- Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. (2013) (418)
- A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo (2015) (412)
- EWSR1‐POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty‐six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene (2010) (411)
- The Diesel Exhaust in Miners Study: A Nested Case–Control Study of Lung Cancer and Diesel Exhaust (2012) (404)
- A Genomics-Based Classification of Human Lung Tumors (2013) (403)
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. (2018) (398)
- Solid cancers after allogeneic hematopoietic cell transplantation. (2009) (395)
- Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore (2003) (384)
- Systemic Mast Cell Disease: ANALYSIS OF 58 CASES AND LITERATURE REVIEW (1988) (372)
- Small Cell Lung Carcinoma (SCLC): A Clinicopathologic Study of 100 Cases With Surgical Specimens (2002) (371)
- Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. (2013) (368)
- Validation of the IASLC/ATS/ERS Lung Adenocarcinoma Classification for Prognosis and Association with EGFR and KRAS Gene Mutations: Analysis of 440 Japanese Patients (2013) (365)
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations (2012) (360)
- Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis (2008) (359)
- Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases (1994) (357)
- Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. (2009) (354)
- Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas (2015) (353)
- Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. (2006) (350)
- Surgical Pathology of the Lung in Wegener's Granulomatosis: Review of 87 Open Lung Biopsies From 67 Patients (1991) (346)
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma. (2018) (340)
- p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma (2012) (329)
- Idiopathic interstitial pneumonias: CT features. (2005) (329)
- Progressive preclinical interstitial lung disease in rheumatoid arthritis. (2008) (328)
- Lung Cancer Screening, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. (2018) (327)
- The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer (2007) (325)
- Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens (2011) (324)
- Interpretation of Head and Neck Biopsies in Wegener's Granulomatosis: A Pathologic Study of 126 Biopsies in 70 Patients (1990) (323)
- Classification of Proliferative Pulmonary Lesions of the Mouse (2004) (321)
- New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. (2000) (314)
- Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint. (2014) (312)
- Advances in neuroendocrine lung tumors. (2010) (305)
- Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. (1999) (303)
- A Clinicopathologic Study of 34 Cases of Diffuse Pulmonary Hemorrhage with Lung Biopsy Confirmation (1990) (302)
- A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium. (2000) (301)
- A Grading System of Lung Adenocarcinomas Based on Histologic Pattern is Predictive of Disease Recurrence in Stage I Tumors (2010) (301)
- Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets (2016) (298)
- Pulmonary Langerhans Cell Granulomatosis (Histiocytosis X) A Clinicopathologic Study of 48 Cases (1993) (287)
- Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study. (2005) (283)
- United States lung carcinoma incidence trends: Declining for most histologic types among males, increasing among females (1996) (271)
- Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. (2002) (269)
- Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. (2005) (264)
- Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. (2005) (263)
- The IASLC Lung Cancer Staging Project: Proposals for the Inclusion of Broncho-Pulmonary Carcinoid Tumors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer (2008) (262)
- Pulmonary atypical carcinoid: predictors of survival in 106 cases. (2000) (258)
- Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual (2017) (257)
- Reproducibility of neuroendocrine lung tumor classification. (1998) (257)
- Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. (2003) (245)
- Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis. (1996) (243)
- Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis. (1994) (242)
- Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing (2011) (242)
- Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. (2004) (241)
- The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification. (2016) (238)
- Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. (1997) (238)
- Visceral Pleural Invasion: Pathologic Criteria and Use of Elastic Stains: Proposal for the 7th Edition of the TNM Classification for Lung Cancer (2008) (235)
- Frequent mutations in chromatin-remodeling genes in pulmonary carcinoids (2014) (230)
- Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? (2007) (227)
- Terminology of endocrine tumors of the uterine cervix: results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. (1997) (227)
- Silicone granulomas: report of three cases and review of the literature. (1985) (226)
- p53 protein accumulates frequently in early bronchial neoplasia. (1993) (225)
- Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. (2010) (221)
- Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement (2015) (220)
- Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas (2012) (220)
- Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller. (2013) (219)
- ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting (2014) (217)
- Significance of systemic mast cell disease with associated hematologic disorders (1988) (215)
- Pathology of lung cancer. (2011) (214)
- Genetic changes in the spectrum of neuroendocrine lung tumors (1999) (212)
- Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors (2018) (210)
- Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. (2000) (205)
- The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (197)
- Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study (2012) (196)
- Extrapulmonary lymphangioleiomyomatosis (LAM): clinicopathologic features in 22 cases. (2000) (195)
- Comprehensive Histologic Assessment Helps to Differentiate Multiple Lung Primary Nonsmall Cell Carcinomas From Metastases (2009) (194)
- Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. (2009) (191)
- Radiologic implications of the 2011 classification of adenocarcinoma of the lung. (2013) (191)
- Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease (2014) (188)
- Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. (2010) (183)
- Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer. (2019) (182)
- Evaluation of two phosphorylation sites improves the prognostic significance of Akt activation in non-small-cell lung cancer tumors. (2006) (179)
- The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015. (2021) (177)
- Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence. (2013) (175)
- International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. (2012) (174)
- Thymic carcinoma outcomes and prognosis: results of an international analysis. (2015) (170)
- Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer (2004) (170)
- Histological Classification of Lung and Pleural Tumours (1999) (168)
- Localized Malignant Mesothelioma (2005) (165)
- PD-L1 Testing for Lung Cancer in 2019: Perspective from the IASLC Pathology Committee. (2019) (163)
- Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas (2009) (162)
- Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome. (1996) (161)
- The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies. (1994) (158)
- Resident cellular components of the human lung: current knowledge and goals for research on cell phenotyping and function. (2008) (158)
- Ki-67 Antigen in Lung Neuroendocrine Tumors: Unraveling a Role in Clinical Practice (2014) (155)
- Lung cancer screening: Clinical practice guidelines in oncology (2012) (154)
- Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing. (2011) (154)
- Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival. (2015) (153)
- The management of subglottic stenosis in patients with wegener's granulomatosis (1992) (153)
- The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification (2016) (152)
- The separation of benign and malignant mesothelial proliferations. (2000) (152)
- Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM). (1997) (152)
- Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm. (2012) (151)
- The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung. (2003) (150)
- Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. (1991) (150)
- Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. (2013) (150)
- Prognostic Immune Markers in Non–Small Cell Lung Cancer (2011) (149)
- Role for activation of matrix metalloproteinases in the pathogenesis of pulmonary lymphangioleiomyomatosis. (2000) (147)
- Mast cell leukemia: report of a case and review of the literature. (1986) (147)
- Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor in Non–Small Cell Lung Cancer (2005) (145)
- Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression. (1995) (145)
- Biphasic synovial sarcomas arising in the pleural cavity. A clinicopathologic study of five cases. (1996) (144)
- Early interstitial lung disease in familial pulmonary fibrosis. (2007) (142)
- Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker (2012) (141)
- The Causes of Death in Patients with Human Immunodeficiency Virus Infection: A Clinical and Pathologic Study with Emphasis on the Role of Pulmonary Diseases (1991) (141)
- Thoracic carcinoids: radiologic-pathologic correlation. (1999) (141)
- Bronchioloalveolar Carcinoma and Lung Adenocarcinoma: The Clinical Importance and Research Relevance of the 2004 World Health Organization Pathologic Criteria (2006) (140)
- Pulmonary and mediastinal glomus tumors--report of five cases including a pulmonary glomangiosarcoma: a clinicopathologic study with literature review. (2000) (138)
- Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers (2009) (137)
- A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma (2012) (135)
- IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY. (2020) (132)
- Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas. (2020) (131)
- An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer (2016) (130)
- Lymphangioleiomyomatosis (LAM): a review of clinical and morphological features. (2000) (130)
- A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective (2017) (128)
- Atypical Pathologic Manifestations of Pneumocystis carinii Pneumonia in the Acquired Immune Deficiency Syndrome: Review of 123 Lung Biopsies from 76 Patients with Emphasis on Cysts, Vascular Invasion, Vasculitis, and Granulomas (1990) (127)
- Associations Between Mutations and Histologic Patterns of Mucin in Lung Adenocarcinoma: Invasive Mucinous Pattern and Extracellular Mucin Are Associated With KRAS Mutation (2014) (126)
- Lung cancer (1995) (125)
- SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas (2019) (125)
- Primary Extranodal Soft Tissue Lymphoma of the Extremities (1987) (124)
- A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma (2012) (124)
- Pleuro-pulmonary endometriosis and pulmonary ectopic deciduosis: a clinicopathologic and immunohistochemical study of 10 cases with emphasis on diagnostic pitfalls. (1998) (123)
- A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities. (2013) (123)
- US lung cancer trends by histologic type (2014) (123)
- Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. (1992) (123)
- Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization. (1992) (122)
- The potential role of BAX and BCL-2 expression in diffuse alveolar damage. (1997) (121)
- Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. (1992) (121)
- Case Report: Lung Disease in World Trade Center Responders Exposed to Dust and Smoke: Carbon Nanotubes Found in the Lungs of World Trade Center Patients and Dust Samples (2009) (121)
- Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. (2000) (120)
- Subtyping of Non-small Cell Lung Carcinoma: A Comparison of Small Biopsy and Cytology Specimens (2011) (120)
- Spread through Air Spaces (STAS) Is an Independent Predictor of Recurrence and Lung Cancer–Specific Death in Squamous Cell Carcinoma (2017) (120)
- Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer (2009) (119)
- Solitary pulmonary papillomas in adults: a clinicopathologic and in situ hybridization study of 14 cases combined with 27 cases in the literature. (1998) (118)
- The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype (2014) (117)
- Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)‐Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis (2019) (117)
- Comparison of patterns of relapse in thymic carcinoma and thymoma. (2008) (115)
- Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma (2013) (114)
- Predictors of Outcomes after Surgical Treatment of Synchronous Primary Lung Cancers (2007) (114)
- Sarcomatoid neoplasms of the lung and pleura. (2010) (114)
- Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features. (1990) (113)
- WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer (2010) (112)
- Pathologic characteristics of drug-induced lung disease. (2004) (110)
- Pleomorphic Epithelioid Diffuse Malignant Pleural Mesothelioma: A Clinicopathological Review and Conceptual Proposal to Reclassify as Biphasic or Sarcomatoid Mesothelioma (2011) (109)
- Peribronchiolar Metaplasia: A Common Histologic Lesion in Diffuse Lung Disease and a Rare Cause of Interstitial Lung Disease: Clinicopathologic Features of 15 Cases (2005) (109)
- Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer (2018) (109)
- The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. (2009) (107)
- Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤3 cm: accuracy and interobserver agreement (2015) (107)
- Lung cancer screening, version 1.2015: featured updates to the NCCN guidelines. (2015) (106)
- The 2015 WHO classification of lung tumors (2014) (106)
- Clinical significance of TTF‐1 protein expression and TTF‐1 gene amplification in lung adenocarcinoma (2009) (106)
- Thin-walled cavities, cysts, and pneumothorax in Pneumocystis carinii pneumonia: further observations with histopathologic correlation. (1990) (105)
- The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification (2009) (104)
- Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. (2001) (104)
- Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. (2012) (103)
- Lung tumours with neuroendocrine differentiation. (2009) (103)
- The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers (2015) (103)
- Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. (1989) (103)
- Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations (2014) (103)
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab. (2021) (102)
- The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases (2017) (100)
- Undifferentiated (Embryonal) Sarcoma of the Liver: Clinical and Pathologic Study of 16 Cases with Emphasis on Immunohistochemical Features (1991) (100)
- Cystic Lung Diseases: Algorithmic Approach. (2016) (99)
- Thoracic Epithelioid Malignant Vascular Tumors: A Clinicopathologic Study of 52 Cases With Emphasis on Pathologic Grading and Molecular Studies of WWTR1-CAMTA1 Fusions (2015) (99)
- Pathology and diagnosis of neuroendocrine tumors: lung neuroendocrine. (2014) (98)
- Pulmonary Pathology of Erdheim-Chester Disease (2000) (98)
- Small Cell Lung Carcinoma Subtypes Defined by ASCL1, NEUROD1, POU2F3 and YAP1: Comprehensive Immunohistochemical and Histopathologic Characterization. (2020) (98)
- Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience. (2011) (97)
- Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). (1988) (97)
- EURACAN/IASLC proposals for updating the histologic classification of pleural mesothelioma: towards a more multidisciplinary approach. (2020) (97)
- The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee (2020) (97)
- Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes. (2016) (97)
- Lung cancer rates convergence in young men and women in the United States: Analysis by birth cohort and histologic type (2003) (96)
- Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. (1995) (96)
- American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002. (2015) (96)
- Granular cell tumors of the lung. Clinicopathologic study of 20 cases. (1995) (96)
- Bronchiolar disorders: a clinical-radiological diagnostic algorithm. (2010) (95)
- Prognostic Significance of Pulmonary Lymphangioleiomyomatosis Histologic Score (2001) (95)
- Comprehensive Pathological Analyses in Lung Squamous Cell Carcinoma: Single Cell Invasion, Nuclear Diameter, and Tumor Budding Are Independent Prognostic Factors for Worse Outcomes (2014) (94)
- Post‐irradiation malignant mesothelioma (1996) (94)
- Calcifying fibrous pseudotumor of pleura. A report of three cases of a newly described entity involving the pleura. (1996) (93)
- Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage. (1996) (92)
- CT Screening for lung cancer: diagnoses resulting from the New York Early Lung Cancer Action Project. (2007) (92)
- A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. (2013) (92)
- Development of the International Thymic Malignancy Interest Group International Database: An Unprecedented Resource for the Study of a Rare Group of Tumors (2014) (91)
- Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer. (1998) (90)
- The Comparative Pathology of Genetically Engineered Mouse Models for Neuroendocrine Carcinomas of the Lung (2015) (89)
- Thymomas Presenting as Pleural Tumors: Report of Eight Cases (1992) (89)
- Outcome of primary neuroendocrine tumors of the thymus: a joint analysis of the International Thymic Malignancy Interest Group and the European Society of Thoracic Surgeons databases. (2015) (88)
- Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton. (1989) (88)
- Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non–Small-Cell Lung Cancers (2013) (88)
- Management of the ectopic ACTH syndrome due to thoracic carcinoids. (1990) (87)
- FDG-PET SUVmax Combined with IASLC/ATS/ERS Histologic Classification Improves the Prognostic Stratification of Patients with Stage I Lung Adenocarcinoma (2012) (87)
- Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. (2007) (87)
- Clear cell "sugar" tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis. (1997) (86)
- Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007 (2008) (84)
- Lung tumors with a rhabdoid phenotype. (1996) (84)
- Sex differences in physiological progression of idiopathic pulmonary fibrosis (2008) (84)
- von Hippel-Lindau disease: radiologic screening for visceral manifestations. (1990) (84)
- Guidelines for Pathologic Diagnosis of Malignant Mesothelioma (2017) (82)
- The histopathology of Erdheim–Chester disease: a comprehensive review of a molecularly characterized cohort (2017) (82)
- The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer (2016) (81)
- Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. (1991) (81)
- Precancer: a conceptual working definition -- results of a Consensus Conference. (2006) (81)
- Surgical management of pheochromocytoma with the use of metyrosine. (1990) (80)
- A preliminary transcriptome map of non-small cell lung cancer. (2002) (80)
- A Role for the Integrin αvβ8 in the Negative Regulation of Epithelial Cell Growth (2000) (80)
- MEN1 gene mutation analysis of high‐grade neuroendocrine lung carcinoma (2000) (79)
- Acquired ALK and RET Gene Fusions as Mechanisms of Resistance to Osimertinib in EGFR-Mutant Lung Cancers. (2018) (79)
- A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer. (2011) (79)
- A Grading system for invasive pulmonary adenocarcinoma: a proposal from the IASLC pathology committee. (2020) (78)
- Pulmonary toxicity associated with erlotinib. (2007) (78)
- Feasibility of multimodality therapy including extended resections in stage IVA thymoma. (2007) (78)
- Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray. (2004) (76)
- Non-neoplastic pulmonary lymphoid lesions (2001) (76)
- Hepatic involvement in mastocytosis: Clinicopathologic correlations in 41 cases (1995) (76)
- Alveolar adenoma: a histochemical, immunohistochemical, and ultrastructural analysis of 17 cases. (1999) (76)
- Unusual aspects of allergic bronchopulmonary fungal disease: report of two cases due to Curvularia organisms associated with allergic fungal sinusitis. (1991) (75)
- Cutaneous Pathology in Wegener's Granulomatosis (1995) (75)
- Insights into pathogenesis of fatal COVID‐19 pneumonia from histopathology with immunohistochemical and viral RNA studies (2020) (75)
- Cytokeratin expression in adrenocortical neoplasia: an immunohistochemical and biochemical study with implications for the differential diagnosis of adrenocortical, hepatocellular, and renal cell carcinoma. (1992) (75)
- Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. (2003) (74)
- Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients (2011) (74)
- Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinoma. (2005) (74)
- Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large cell carcinoma (2012) (73)
- The pathology of interstitial lung disease in nylon flock workers. (1999) (73)
- Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. (2004) (73)
- Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. (2008) (73)
- Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 (2021) (73)
- Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report. (2021) (70)
- Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines. (2010) (69)
- A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee (2020) (69)
- A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies (2010) (68)
- Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM Classification based on recommendations of the IASLC Staging Committee (2009) (68)
- The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. (2014) (68)
- Tumor Mutation Burden: Promises and Challenges A Perspective from the IASLC Pathology Committee. (2020) (68)
- Diffuse Pulmonary Hemorrhage: An Uncommon Manifestation of Wegener's Granulomatosis (1987) (67)
- Pulmonary Light Chain Deposition Disease: Report of Five Cases and Review of the Literature (2007) (66)
- Pathologic findings associated with interleukin-2-based immunotherapy for cancer: a postmortem study of 19 patients. (1990) (65)
- Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma (2019) (65)
- Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group. (2015) (65)
- Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor–related Pneumonitis. An Official American Thoracic Society Research Statement (2019) (65)
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma. (2016) (65)
- Usual interstitial pneumonia. (2001) (64)
- Pseudomesotheliomatous adenocarcinoma: a reappraisal. (1992) (64)
- Lung cancer staging: a concise update (2018) (63)
- Adenomatoid tumors of the pleura. (1996) (63)
- Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study (2018) (63)
- Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions. (2000) (63)
- Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID‐19 pneumonia in Wuhan, China (2020) (63)
- Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. (2004) (62)
- Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance. (2013) (62)
- Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis. (1991) (62)
- Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia. (2001) (62)
- Pathologic Findings of Lung Tumors Diagnosed on Baseline CT Screening (2006) (62)
- Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers. (1993) (61)
- Primary pulmonary sarcoma with morphologic features of monophasic synovial sarcoma and chromosome translocation t(X; 18). (1996) (61)
- Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsets. (2013) (60)
- No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. (1993) (60)
- New approaches to small cell lung cancer therapy : from the laboratory to the clinic. (2020) (60)
- Proliferation and cellular phenotype in lymphomatoid granulomatosis: implications of a higher proliferation index in B cells. (1998) (60)
- A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions (2017) (59)
- Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets (2019) (59)
- New Insights on Diagnostic Reproducibility of Biphasic Mesotheliomas: A Multi‐Institutional Evaluation by the International Mesothelioma Panel From the MESOPATH Reference Center (2018) (58)
- Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance (2011) (58)
- Paradigm shifts in lung cancer as defined in the new IASLC/ATS/ERS lung adenocarcinoma classification (2011) (58)
- The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor (R) Descriptors for Non-Small Cell Lung Cancer. (2019) (58)
- Reevaluation and Reclassification of Resected Lung Carcinomas Originally Diagnosed as Squamous Cell Carcinoma Using Immunohistochemical Analysis (2015) (58)
- An ultrastructural study of In vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin‐2 (1991) (57)
- Multifocal verruciform xanthoma of the upper aerodigestive tract in a child with a systemic lipid storage disease. (1989) (57)
- CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. (1991) (57)
- Pulmonary dysfunction in adults with nephropathic cystinosis. (2001) (57)
- Initial Experience With Lung Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors. (2017) (57)
- Pulmonary metastases: MR imaging with surgical correlation--a prospective study. (1992) (56)
- Desmoglein 3 as a prognostic factor in lung cancer. (2007) (56)
- Bronchiolar Adenoma: Expansion of the Concept of Ciliated Muconodular Papillary Tumors With Proposal for Revised Terminology Based on Morphologic, Immunophenotypic, and Genomic Analysis of 25 Cases (2018) (56)
- Lung Cancer Pathology: Current Concepts. (2020) (55)
- Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis. (1997) (55)
- Tumor genetics and survival of thymic neuroendocrine neoplasms: A multi‐institutional clinicopathologic study (2014) (55)
- Augmented pulmonary IL-4 and IL-13 receptor subunit expression in idiopathic interstitial pneumonia (2004) (54)
- Adrenal cortical neoplasms in the pediatric and adolescent age group. Clinicopathologic study of 30 cases with emphasis on epidemiological and prognostic factors. (1992) (54)
- Stage IV Lung Carcinoids: Spectrum and Evolution of Proliferation Rate, Focusing on Variants with Elevated Proliferation Indices (2019) (54)
- SMAD6 contributes to patient survival in non-small cell lung cancer and its knockdown reestablishes TGF-beta homeostasis in lung cancer cells. (2008) (54)
- Cavitary Lung Diseases: A Clinical‐Radiologic Algorithmic Approach (2018) (53)
- Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements (2019) (53)
- Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. (1993) (53)
- Tumor Budding Correlates With the Protumor Immune Microenvironment and Is an Independent Prognostic Factor for Recurrence of Stage I Lung Adenocarcinoma. (2015) (52)
- Expression profiling and identification of potential molecular targets for therapy in pulmonary large-cell neuroendocrine carcinoma. (2011) (52)
- Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study (2010) (51)
- Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease. (2005) (51)
- Lung cancer screening. (2003) (50)
- Oral squamous cell carcinoma arising in a patient with long-standing lichen planus. A case report. (1990) (50)
- Serum anti-SS-B/La and IgA rheumatoid factor are markers of salivary gland disease activity in primary Sjögren's syndrome. (1992) (50)
- V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma (2019) (50)
- Early lung cancer action project pathology protocol. (2003) (49)
- Comparison of DNA topoisomerase IIα expression in small cell and nonsmall cell carcinoma of the lung: In search of a mechanism of chemotherapeutic response (1996) (49)
- Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma. (2001) (49)
- The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma. (2020) (49)
- Primary Anaplastic Large Cell Lymphoma of the Lung: A Clinicopathologic Study of Five Patients (2000) (49)
- Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase. (2014) (49)
- Mucinous cystadenoma of the lung. A report of two cases with immunohistochemical and ultrastructural analysis. (1990) (48)
- Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: Napsin A expression and genomic alterations (2017) (48)
- Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach (2019) (48)
- Multidisciplinary management of advanced lung neuroendocrine tumors. (2015) (48)
- Multifocal micronodular pneumocyte hyperplasia: a distinctive pulmonary manifestation of tuberous sclerosis. (1995) (47)
- p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer. (1998) (47)
- Histologic considerations for individualized systemic therapy approaches for the management of non-small cell lung cancer. (2009) (46)
- Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society. (2021) (46)
- Primary Pigmented Nodular Adrenocortical Disease: A Light and Electron Microscopic Study of Eight Cases (1989) (45)
- Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung. (2019) (45)
- Myocarditis or acute myocardial infarction associated with interleukin‐2 therapy for cancer (1990) (45)
- Expression of Telomerase Reverse Transcriptase (TERT) in Malignant Mesotheliomas (2002) (45)
- THREE-DIMENSIONAL HISTOLOGIC, IMMUNOHISTOCHEMICAL AND MULTIPLEX IMMUNOFLUORESCENCE ANALYSIS OF DYNAMIC VESSEL CO-OPTION OF SPREAD THROUGH AIR SPACES (STAS) IN LUNG ADENOCARCINOMA. (2019) (45)
- Prognostic Impact of Immune Microenvironment in Lung Squamous Cell Carcinoma: Tumor-Infiltrating CD10+ Neutrophil/CD20+ Lymphocyte Ratio as an Independent Prognostic Factor (2015) (45)
- Retroperitoneal germ cell tumors in childhood. A clinical and pathologic study of 11 cases (1985) (44)
- Primary bilateral adrenocortical causes of Cushing's syndrome. (1991) (44)
- Adenocarcinoma simulating mesothelioma: a clinicopathologic and immunohistochemical study of 29 cases. (1998) (44)
- Thyroid transcription factor‐1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma (2013) (44)
- Hematopathology of the bone marrow in pediatric cutaneous mastocytosis. A study of 17 patients. (1989) (44)
- Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. (2004) (43)
- Surgical pathology of the lung in chronic granulomatous disease. (1994) (43)
- Decrease in interleukin 2-induced vascular leakage in the lungs of mice by administration of recombinant interleukin 1 alpha in vivo. (1989) (43)
- Terminology and classification of neuroendocrine neoplasms of the larynx (2011) (43)
- A role for the integrin alphavbeta8 in the negative regulation of epithelial cell growth. (2000) (43)
- Mucinous (so-called colloid) carcinomas of lung. (1992) (43)
- Adenomatoid tumor of the adrenal gland with ultrastructural and immunohistochemical demonstration of a mesothelial origin. (1990) (42)
- Bcl-2 immunohistochemistry in a surgical series of non-small cell lung cancer patients. (1998) (42)
- Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database (2017) (42)
- Comparison of outcomes between neuroendocrine thymic tumours and other subtypes of thymic carcinomas: a joint analysis of the European Society of Thoracic Surgeons and the International Thymic Malignancy Interest Group. (2016) (42)
- Ki 67 is an Independent Predictive Biomarker of Cancer Specific and Local Recurrence-Free Survival After Lung Tumor Ablation (2013) (41)
- Respiratory cryptosporidiosis in a patient with malignant lymphoma. Report of a case and review of the literature. (1990) (41)
- Lung cancer after Hodgkin's disease. (1995) (41)
- Management and outcomes of relapse after treatment for thymoma and thymic carcinoma. (2011) (41)
- Pulmonary Mucoepidermoid Carcinoma With Prominent Tumor-Associated Lymphoid Proliferation (2005) (41)
- KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma (2016) (41)
- A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia (2015) (41)
- Solid and hematologic malignancies in 60 patients with systemic mast cell disease. (1989) (41)
- Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia (2006) (40)
- Clinical Outcomes with Perioperative Chemotherapy in Sarcomatoid Carcinomas of the Lung (2012) (40)
- Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. (1997) (40)
- The histopathologic spectrum in Mycobacterium marinum infection. (1985) (40)
- Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy. (2017) (40)
- Intraoperative photodynamic therapy for malignant mesothelioma. (1990) (40)
- Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma. (2013) (40)
- Integrative Genomic Characterization Identifies Molecular Subtypes of Lung Carcinoids. (2019) (39)
- Mitotic counting in surgical pathology: sampling bias, heterogeneity and statistical uncertainty (2001) (39)
- Adaptive Neoadjuvant Chemotherapy Guided by 18F‐FDG PET in Resectable Non–Small Cell Lung Cancers: The NEOSCAN Trial (2016) (38)
- p53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients with non-small cell lung cancer. (1998) (38)
- Mandibular osteomyelitis in a patient with sickle cell anemia: report of case. (1990) (38)
- Pulmonary neuroendocrine tumors: What (little) do we know? (2006) (38)
- Pulmonary lymphangioleiomyomatosis. Diagnosis based on results of transbronchial biopsy and immunohistochemical studies and correlation with high-resolution computed tomography findings. (1994) (37)
- Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis (2009) (37)
- Consistent copy number changes and recurrent PRKAR1A mutations distinguish Melanotic Schwannomas from Melanomas: SNP‐array and next generation sequencing analysis (2015) (37)
- Unique pulmonary presentation of an angiomyolipoma. Analysis of clinical, radiographic, and histopathologic features. (1995) (37)
- Hypersensitivity pneumonitis and pulmonary vasculitis with eosinophilia in a patient taking an L-tryptophan preparation. (1990) (36)
- Locally recurrent parathyroid neoplasms as a cause for recurrent and persistent primary hyperparathyroidism. (1991) (36)
- Pathologic classification of adenocarcinoma of lung (2013) (36)
- Primary Adrenal Causes of Cushing's Syndrome; Diagnosis and Surgical Management (1989) (36)
- A combined small cell and spindle cell carcinoma of the lung. Report of a unique case with immunohistochemical and ultrastructural studies. (1992) (36)
- Adult-onset urticaria pigmentosa and systemic mast cell disease. (1985) (36)
- Classification of lung cancer. (2011) (35)
- Isolated lung perfusion with tumor necrosis factor: a swine model in preparation of human trials. (1994) (35)
- Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy. (2002) (35)
- Standardized terminology and nomenclature for respiratory cytology: The Papanicolaou Society of Cytopathology guidelines (2016) (35)
- Procedure‐Specific Risk Prediction for Recurrence in Patients Undergoing Lobectomy or Sublobar Resection for Small (≤2 cm) Lung Adenocarcinoma: An International Cohort Analysis (2019) (35)
- Tumor spread through air spaces (STAS) is a predictor of occult lymph node metastasis in clinical stage IA lung adenocarcinoma. (2020) (35)
- Counting mitoses: SI(ze) matters! (2021) (35)
- Pathology of pulmonary vasculitis. (2004) (35)
- Q fever. A clinicopathologic study of five cases. (1986) (35)
- Hyperplasia of type II pneumocytes in pulmonary lymphangioleiomyomatosis. (2000) (34)
- Pneumocytic Adenomyoepithelioma: A Distinctive Lung Tumor With Epithelial, Myoepithelial, and Pneumocytic Differentiation (2007) (34)
- Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. (2013) (34)
- A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma. (2020) (34)
- Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas. (2017) (34)
- Unusual sclerosing haemangiomas and sclerosing haemangioma-like lesions, and the value of TTF-1 in making the diagnosis. (2002) (33)
- Diagnostic reproducibility of squamous cell carcinoma (SC) in the era of histology-directed non-small cell lung cancer (NSCLC) chemotherapy: A large prospective study. (2016) (33)
- [New WHO classification of lung adenocarcinoma and preneoplasia]. (2016) (32)
- Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center. (2020) (32)
- Protocol for the examination of specimens from patients with primary non-small cell carcinoma, small cell carcinoma, or carcinoid tumor of the lung. (2009) (32)
- Kaposi's sarcoma of the parotid gland in acquired immunodeficiency syndrome. (1989) (32)
- Visceral pleural invasion does not affect recurrence or overall survival among patients with lung adenocarcinoma ≤ 2 cm: a proposal to reclassify T1 lung adenocarcinoma. (2013) (32)
- Lung adenocarcinoma subtypes based on expression of human airway basal cell genes (2013) (31)
- A report of familial carotid body tumors and multiple extra-adrenal pheochromocytomas. (1991) (31)
- The Fake Fat Phenomenon in Organizing Pleuritis: A Source of Confusion With Desmoplastic Malignant Mesotheliomas (2011) (31)
- Smoking-related idiopathic interstitial pneumonia (2014) (30)
- MR and CT findings in pulmonary artery sarcoma. (1989) (30)
- Predicting pulmonary adenocarcinoma outcome based on a cytology grading system (2012) (30)
- High SUVmax on FDG-PET Indicates Pleomorphic Subtype in Epithelioid Malignant Pleural Mesothelioma: Supportive Evidence to Reclassify Pleomorphic as Nonepithelioid Histology (2012) (30)
- IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome. (1989) (29)
- Surgical management of pulmonary infections in chronic granulomatous disease of childhood. (1993) (29)
- Liposarcoma of the pleural cavity: clinical and pathologic features of 4 cases with a review of the literature. (2000) (29)
- Altered macrophage activity and tumor necrosis factor: tumor necrosis and host cachexia. (1989) (29)
- p53 mutations and occupational exposures in a surgical series of lung cancers. (1996) (28)
- Cystic fibrohistiocytic tumours presenting in the lung: primary or metastatic disease? (2003) (28)
- Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel (2019) (28)
- Expansion of the concept of micropapillary adenocarcinoma to include a newly recognized filigree pattern as well as the classical pattern based on 1468 Stage I lung adenocarcinomas. (2019) (28)
- Primary signet ring cell adenocarcinoma of the bladder. (1989) (27)
- New Approaches to SCLC Therapy: From the Laboratory to the Clinic (2020) (27)
- Cancer antigen profiling for malignant pleural mesothelioma immunotherapy: expression and coexpression of mesothelin, cancer antigen 125, and Wilms tumor 1 (2017) (27)
- Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society. (2021) (27)
- Endobronchial variant of sclerosing hemangioma of the lung: histological and cytological features on endobronchial material (2004) (27)
- Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis. (2007) (26)
- Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung (2017) (26)
- Large cell neuroendocrine carcinoma of the head and neck. (2012) (26)
- Standardized terminology and nomenclature for respiratory cytology: The Papanicolaou Society of Cytopathology guidelines (2016) (26)
- Nonspecific interstitial pneumonia (NSIP). (2001) (26)
- Report of workshop on lymphangioleiomyomatosis (1999) (25)
- Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice. (1990) (25)
- Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids† (2018) (25)
- Diagnosis and Evaluation of Hypersensitivity Pneumonitis (2021) (25)
- Aspiration cytomorphology of fetal adenocarcinoma of the lung. (2010) (25)
- Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study (2014) (25)
- Pathologic and molecular features of screening low-dose computed tomography (LDCT)-detected lung cancer: a baseline and 2-year repeat study. (2008) (25)
- Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients. (1988) (24)
- Pediatric AIDS-associated lymphocytic interstitial pneumonia and pulmonary arterio-occlusive disease: role of VCAM-1/VLA-4 adhesion pathway and human herpesviruses. (1999) (24)
- Erratum: Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium (Cancer Research (April 1, 2004) 64 (2307-2316)) (2004) (24)
- Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes (2021) (24)
- Second primary cancers after thymoma (2003) (24)
- A Plasminogen Activator Inhibitor-1 Promoter Polymorphism and Idiopathic Interstitial Pneumonia (2003) (23)
- The 2021 World Health Organization Classification of Tumors of the Pleura: Advances since the 2015 Classification. (2022) (23)
- Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance (2018) (23)
- The International Association Study Lung Cancer (IASLC) Strategic Screening Advisory Committee (SSAC) response to the USPSTF recommendations. (2014) (23)
- Clinically occult Leydig cell tumor presenting with gynecomastia. (1989) (23)
- Pathologic review of the Mayo Lung Project (2002) (23)
- Histological grading in lung cancer: one system for all or separate systems for each histological type? (2016) (23)
- The frequency of perineurial ductules in vasitis nodosa. (1984) (22)
- Peripheral pulmonary papillary/glandular neoplasms with ciliated cells and a component of well‐differentiated adenocarcinoma: report of three tumours (2010) (22)
- Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy. (1990) (22)
- SCLC Subtypes De fi ned by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization (2020) (22)
- What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology? (2018) (22)
- Isolation and sequence analysis of amyloid protein AA from a patient with cystic fibrosis. (1988) (21)
- Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I‐IIA Lung Adenocarcinoma (2018) (21)
- Identification of TDE2 gene and its expression in non‐small cell lung cancer (2003) (21)
- Association of Lymphangioleiomyomatosis (LAM) with Endosalpingiosis in the Retroperitoneal Lymph Nodes: Report of Two Cases (2001) (21)
- Identification and Functional Characterization of EGFR V769M, a Novel Germline Variant Associated With Multiple Lung Adenocarcinomas. (2017) (21)
- Benign vascular invasion in vasitis nodosa. (1985) (21)
- Outcomes after neoadjuvant or adjuvant chemotherapy for cT2‐4N0‐1 non–small cell lung cancer: A propensity‐matched analysis (2019) (21)
- Diffuse panbronchiolitis: histologic diagnosis in unsuspected cases involving North American residents of Asian descent. (1998) (21)
- Thoracic Myoepithelial Tumors: A Pathologic and Molecular Study of 8 Cases With Review of the Literature (2015) (21)
- Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues (2020) (20)
- Amyloidosis as a complication of cystic fibrosis. (1985) (20)
- Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration (2015) (20)
- Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma (2020) (20)
- Pulmonary fibrosis associated with tocainide: report of a case with literature review. (1990) (20)
- Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist. (2018) (20)
- Megakaryoblastic transformation of chronic granulocytic leukemia (1987) (19)
- Papillary cystadenoma of the epididymis. A report of three cases with lectin histochemistry. (1990) (19)
- Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies (2010) (19)
- Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification. (2016) (18)
- Surgical Management of Pheochromocytoma with the Use of Metyrosine (1991) (18)
- Small cell and neuroendocrine tumors of the lung (2015) (18)
- NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2022. (2022) (18)
- Absence of human herpesvirus-8 in pulmonary inflammatory myofibroblastic tumor: immunohistochemical and molecular analysis of 20 cases (2007) (17)
- Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma (2016) (17)
- Primary myoepithelial carcinoma of the lung: a rare entity treated with parenchymal sparing resection (2011) (17)
- Exuberant type 2 pneumocyte hyperplasia associated with spontaneous pneumothorax: secondary reactive change mimicking adenocarcinoma (2007) (17)
- Sodium polystyrene sulfonate (kayexalate) aspiration: histologic appearance and infrared microspectrophotometric analysis of two cases. (1996) (17)
- A multi-center, randomized, double-blind phase II study comparing temozolomide (TMZ) plus either veliparib (ABT-888), a PARP inhibitor, or placebo as 2nd or 3rd-line therapy for patients (Pts) with relapsed small cell lung cancers (SCLCs). (2016) (17)
- Large No More: The Journey of Pulmonary Large Cell Carcinoma from Common to Rare Entity. (2019) (17)
- Rapid EGFR Mutation Detection Using the Idylla Platform: Single institution experience of 1200 cases analyzed by an in-house developed pipeline and comparison with concurrent next-generation sequencing results. (2020) (16)
- BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis (2018) (16)
- Pathology of the lymph node and spleen in systemic mast cell disease. (1988) (16)
- Primary basaloid squamous cell carcinoma of the trachea. (1995) (16)
- Characterization of High‐grade Neuroendocrine Tumors of the Lung in Relation to menin Mutations (2000) (16)
- Telomere length, telomerase activity, and expressions of human telomerase mRNA component (hTERC) and human telomerase reverse transcriptase (hTERT) mRNA in pulmonary neuroendocrine tumors. (2007) (16)
- Premature alveolar bone loss in Erdheim-Chester disease. (1990) (16)
- Disseminated human malignant melanoma in congenitally immune-deficient (bg/nu/xid) mice. (1991) (16)
- Metastatic mature teratoma in lung following testicular embryonal carcinoma and teratocarcinoma. (1993) (15)
- Common and uncommon manifestations of wegener's granulomatosis. (1994) (15)
- The 2021 WHO Classi fi cation of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors? (2022) (15)
- Carcinoma In Situ at the Bronchial Resection Margin: A Review (2011) (15)
- Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer (2021) (15)
- Pulmonary Microcystic Fibromyxoma: Report of 3 Cases (2006) (15)
- Immunostaining for hemoglobin in two cases of myospherulosis. (1986) (14)
- In vivo administration of interferon alpha and interleukin 2 induces proliferation of lymphoid cells in the organs of mice. (1990) (14)
- Invasive Mucinous Adenocarcinomas with Spatially Separate Lung Lesions: Analysis of Clonal Relationship by Comparative Molecular Profiling. (2021) (14)
- MA12.05 Can Tumor Spread through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively? (2017) (14)
- Diagnosis and Evaluation of Hypersensitivity Pneumonitis: CHEST Guideline and Expert Panel Report - Executive Summary. (2021) (13)
- Reprint of "Introduction to 2021 WHO Classification of Thoracic Tumors". (2022) (13)
- Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma. (2015) (12)
- Occult primary parotid gland acinic cell adenocarcinoma presenting with extensive lung metastasis. (2007) (12)
- Sarcoid in cancer patients: clinical characteristics and associated disease status. (2015) (12)
- Non-Neoplastic Disorders of the Lower Respiratory Tract (2011) (12)
- A hitherto unreported pulmonary complication in an IV heroin user. (2008) (12)
- Interleukin-la Reduces the Severity of the Vascular Leak Syndrome Produced by Interleukin-2 and Interleukin-2 Plus Interferon-a (1994) (12)
- Recent advances in our understanding of lung cancer visceral pleural invasion and other forms of minimal invasion: implications for the next TNM classification. (2013) (12)
- MA11.07 Improved Small Cell Lung Cancer (SCLC) Response Rates with Veliparib and Temozolomide: Results from a Phase II Trial (2017) (12)
- HISTOPATHOLOGIC STUDIES ON LYMPHANGIOLEIOMYOMATOSIS (1999) (12)
- Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore 1 1 This is a US government work. There are no restrictions on its use. (2003) (12)
- Utility of core biopsy to identify histologic subtype and predict outcome for lung adenocarcinoma. (2019) (12)
- Sarcomatoid renal carcinoma with angiosarcomatoid component (1992) (11)
- Brief Report: Molecular characterization of peritoneal mesotheliomas. (2021) (11)
- Neuroendocrine Lung Tumors (2006) (11)
- Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab (2013) (11)
- NEUROENDOCRINE TUMORS OF THE LUNG (1999) (11)
- Slow-onset asthma deaths have more eosinophils and health care utilization than rapid-onset deaths. (2008) (11)
- State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach. (2020) (11)
- Updated protocol for the examination of specimens from patients with carcinoma of the lung. (2003) (11)
- Acute Fibrinous and Organizing Pneumonia (2009) (11)
- POU2F3 in SCLC: Clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC. (2022) (10)
- Bladder calcifications after photodynamic therapy: analysis of a rare complication. (1996) (10)
- Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma? (2014) (10)
- Pleomorphic carcinoma (spindle and giant cell) of the lung. (1994) (10)
- High expression of SNIP1 correlates with poor prognosis in non-small cell lung cancer and SNIP1 interferes with the recruitment of HDAC1 to RB in vitro. (2013) (10)
- Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway (2021) (10)
- Acquired immunodeficiency syndrome may present as severe restrictive lung disease. (1989) (9)
- Intractable desquamative interstitial pneumonia in a tattooed man. (2006) (9)
- P3.01-029 Cases Demonstrating Spread Through Air Spaces (STAS) Reflects Invasive Growth and Not an Artifact: Topic: Morphology (2017) (9)
- P53 mutations in human adrenocortical neoplasms (1994) (9)
- Tumor and Tumor-Associated Macrophage PD-L1 Expression is Associated with Adjuvant Chemotherapy Benefit in Lung Adenocarcinoma. (2021) (9)
- Intentional Segmentectomy for Clinical T1N0 Non-Small Cell Lung Cancer: Survival Differs by Segment. (2020) (9)
- Pleomorphic rhabdomyosarcoma arising in association with the right pulmonary artery. (1994) (8)
- Secondary (AA) amyloidosis in cystic fibrosis. A report of three cases. (1986) (8)
- Variable Prostaglandin E 2 Resistance in Fibroblasts from Patients with Usual Interstitial Pneumonia (2007) (8)
- Resident Cellular Components of the Human Lung (2012) (8)
- Variants of adenocarcinoma (2015) (8)
- Immunoperoxidase staining of fine needle aspiration specimens previously stained by the Papanicolaou technique. (1987) (8)
- OA07.06 In Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread through Air Spaces (2017) (8)
- Diagnostic problems in surgical pathology of the adrenal glands. (1995) (8)
- Endotracheal myoepithelioma. (2011) (8)
- Lung biopsy interpretation in the acquired immunodeficiency syndrome: experience of the National Institutes of Health with literature review. (1989) (8)
- Executive Summary Diagnosis and Evaluation of Hypersensitivity Pneumonitis (2021) (8)
- Vasculitis of the lung. (1996) (8)
- Alterations of p 14 ARF , p 53 , and p 73 Genes Involved in the E 2 F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma (2001) (8)
- Development of Standard Operating Procedure (SOP) of Micro-computed tomography (micro-CT) in Pathology (2019) (8)
- Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer exhibits antitumor efficacy with low toxicity. (2022) (8)
- Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM). (2011) (7)
- Spread Through Air Spaces (STAS) in Non−Small Cell Lung Carcinoma (2021) (7)
- Classification of neuroendocrine tumors of the lung (1997) (7)
- Tumoral CD10 Expression Correlates with Aggressive Histology and Prognosis in Patients with Malignant Pleural Mesothelioma (2015) (7)
- Primary Pulmonary Osteosarcoma: A Report of 4 Cases and a Review of the Literature (2011) (7)
- Surgical pathology of pulmonary infections. (1995) (7)
- Erratum: Idiopathic nonspecific interstitial pneumonia: Report of an American Thoracic Society project (American Journal of Respiratory and Critical Care Medicine (2008) 177, (1338-1347)) (2008) (7)
- Idiopathic Interstitial Pneumonias : CT Features 1 (2005) (6)
- The tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer (2014) (6)
- Diffuse Thymic Fibrosis: Histologic Pattern of Injury or Distinct Entity? (2010) (6)
- Phase I study of obatoclax mesylate (GX15-070MS), a bcl-2 antagonist, plus topotecan in relapsed small cell lung carcinoma and other solid tumors. (2016) (6)
- Preponderance of High‐Grade Histologic Subtype in Autologous Metastases in Lung Adenocarcinoma (2017) (6)
- Algorithmic approach to the diagnosis of organizing pneumonia: a correlation of clinical, radiological and pathological features. (2022) (6)
- Sarcomatoid renal carcinoma with angiosarcomatoid component. Light microscopic and immunohistochemical study. (1992) (6)
- IASLC Global Survey on PD-L1 Testing for Non-Small Cell Lung Cancer. (2021) (6)
- Brief Report: Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations. (2019) (5)
- Large Cell Neuroendocrine Carcinoma (2012) (5)
- Phase II Study of Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer (2010) (5)
- The International Association for the Study of Lung Cancer (IASLC) Molecular Database Project: Objectives, Challenges and Opportunities. (2021) (5)
- Silicone-induced endocarditis. A complication of transvenous cardiac pacing catheterization. (1986) (5)
- Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors (2018) (5)
- Node Doubt: Rigorous Surgical Nodal Procurement Combined With Thorough Pathologic Evaluation Improves Non-Small Cell Lung Carcinoma Staging Accuracy. (2016) (5)
- Spread Through Air Spaces Is Prognostic in Neuroendocrine Lung Tumors and Can Be Distinguished From Artifacts. (2020) (4)
- Interleukin-1 alpha reduces the severity of the vascular leak syndrome produced by interleukin-2 and interleukin-2 plus interferon-alpha. (1994) (4)
- OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer (2018) (4)
- Preleukemia/Dysmyelopoietic Syndrome (1985) (4)
- Saddle embolism of the aorta. A complication of streptokinase therapy. (1986) (4)
- The Ki-67 antigen in the new 2021 World Health Organization classification of lung neuroendocrine neoplasms (2021) (4)
- Saddle Embolism of the Aorta (1986) (4)
- Artificial intelligence (AI)–powered pathologic response (PathR) assessment of resection specimens after neoadjuvant atezolizumab in patients with non-small cell lung cancer: Results from the LCMC3 study. (2021) (4)
- Pulmonary Myoepithelial Tumors With Exuberant Reactive Pneumocytes (2019) (4)
- Forty Years of the International Association for Study of Lung Cancer Pathology Committee (2014) (4)
- Ectopic (mediastinal) parathyroid adenoma with prominent lymphocytic infiltration. (2009) (4)
- F-118COMPARISON OF OUTCOMES BETWEEN NEUROENDOCRINE THYMIC TUMOURS AND OTHER SUBTYPES OF THYMIC CARCINOMAS: A JOINT ANALYSIS OF THE EUROPEAN SOCIETY OF THORACIC SURGEONS (ESTS) AND THE INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP (ITMIG) (2015) (3)
- Immune check‐point inhibitor‐related pneumonitis: acute lung injury with rapid progression and organising pneumonia with less severe clinical disease (2022) (3)
- Mutations AKT 1 / PIK 3 CA S and Presence of KRA / EGFR Biomarker-Verified Squamous Carcinoma of Lung : Lack of Clarifying the Spectrum of Driver Oncogene Mutations in (2012) (3)
- Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset (2022) (3)
- Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (2015) (3)
- Pulmonary lymphangioleiomyomatosis. (2010) (3)
- E05-02: IASLC Staging Project: T-desriptors (2007) (3)
- Pathology of lung preneoplasia (2006) (3)
- Integration and application of clinical practice guidelines for the diagnosis of idiopathic pulmonary fibrosis and fibrotic hypersensitivity pneumonitis. (2022) (3)
- Predicting spread through air spaces (STAS) preoperatively: can imaging help? (2019) (3)
- PUB016 A Multi-National Cohort Validation of Procedure–Specific Nomograms to Predict Recurrence for Small Lung Adenocarcinomas (2017) (3)
- Molecular differences across invasive lung adenocarcinoma morphological subgroups (2020) (3)
- Transdiaphragmatic amyloidoma. (2008) (3)
- Interstitial lung disease. (2008) (3)
- 2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification. (2022) (3)
- Prognostic Value of Fibroblastic Foci in Patients With Usual Interstitial Pneumonia (2001) (3)
- A Clinical-Radiological Diagnostic Algorithm (2015) (3)
- The Newly Described Filigree Pattern Is an Expansion of the Micropapillary Adenocarcinoma Concept Rather Than a Proposed New Subtype. (2020) (3)
- Which Biopsy to Diagnose Interstitial Lung Disease? A Call for Evidence and Unity (2019) (3)
- OA 18.06 Three-Dimensional Assessment of Spread Through Air Spaces in Lung Adenocarcinoma: Insights and Implications (2017) (3)
- Capillaritis and Pulmonary Hemorrhage in Wegenerʼs Granulomatosis (1989) (3)
- Oncodiagnosis panel: 1999. Cancer of the lung: oncodiagnosis. (2001) (3)
- Pathologic Assessment of Lung Squamous Cell Carcinoma After Neoadjuvant Immunotherapy. (2021) (3)
- REPORT OF TWO INTERESTING CASES. (1899) (2)
- Alterations of p14 ARF , p53 , and p73 Genes Involved in the E2F-1-mediated Apoptotic Pathways in Non-Small Cell Lung Carcinoma (2001) (2)
- Liposarcoma of the Pleural Cavity (2009) (2)
- Diagnostic criteria for idiopathic pulmonary fibrosis - Authors' reply. (2018) (2)
- THE NEED FOR A NEW CLASSIFICATION FOR LUNG AND PLEURAL TUMORS (1999) (2)
- The New WHO/IASLC Classification of Neuroendocrine Lung Tumors (1999) (2)
- E12-01: NCI Director's challenge gene profiling of lung adenocarcinomas: impact on histologic classification (2007) (2)
- Mini-symposia Pathology III—Neuroendocrine propertiesClassification of neuroendocrine tumors of the lung (1994) (2)
- Cancer A Preliminary Transcriptome Map of Non-Small Cell Lung (2002) (2)
- Type A thymoma presenting with bone metastasis (2018) (2)
- A Review of Clinical and Morphological Features (2000) (2)
- 5-day dosing schedule of temozolomide in relapsed sensitive or refractory small cell lung cancer (SCLC) and methyl-guanine-DNA methyltransferase (MGMT) analysis in a phase II trial. (2012) (2)
- Pathology of pulmonary, pleural, and mediastinal malignancies other than lung carcinoma (1997) (2)
- Pathology of Usual Interstitial Pneumonia (2003) (2)
- 1463OPROSPECTIVE MOLECULAR EVALUATION OF SMALL CELL LUNG CANCER (SCLC) UTILIZING THE COMPREHENSIVE MUTATION ANALYSIS PROGRAM (MAP) AT MEMORIAL SLOAN KETTERING CANCER CENTER (MSKCC). (2014) (2)
- Pitfalls in the Diagnosis of Malignant Mesothelioma (2005) (2)
- MA22.05 Impact of Tumor Spread Through Air Spaces (STAS) in Lung Neuroendocrine Tumors (NETs) (2018) (2)
- Is pneumonectomy mandatory after transection of the left main pulmonary artery? (2010) (2)
- P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer (2019) (2)
- Proposal for WHO histological typing of lung tumors: Adenocarcinoma and related tumors (1997) (1)
- 545 Allelic deletion analysis of the fragile histidine triad (FHIT) gene in non-small cell lung cancer (NSCLC) (1997) (1)
- PREDICTING IPF VS NSIP WITHOUT A SURGICAL LUNG BIOPSY (2007) (1)
- IASLC Staging Project: T-desriptors: E05-02 (2007) (1)
- Defining morphologic features of invasion in pulmonary non-mucinous adenocarcinoma with lepidic growth - A proposal by the IASLC Pathology Committee. (2022) (1)
- P3.01-021 Reproducibility of Comprehensive Histologic Assessment and Refining Histologic Criteria in P Staging of Multiple Tumor Nodules: Topic: Morphology (2017) (1)
- Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway (2021) (1)
- P3.13-019 Preoperative Needle Biopsy Does Not Increase the Risk of Pleural Recurrence in ≤3cm Lung Adenocarcinoma (2017) (1)
- Evolutionary characterisation of lung adenocarcinoma morphology in TRACERx (2023) (1)
- Surgical Lung Biopsy in the Diagnosis of Idiopathic NSIP: Do We Always Need It in the Initial Approach? (2009) (1)
- S-023: The Diesel Exhaust in Miners Study (2012) (1)
- Lung Cancer: Overview and Classification (2008) (1)
- Diagnosis of Idiopathic Pulmonary Fibrosis An Of fi cial ATS / ERS / JRS / ALAT Clinical Practice Guideline : Executive Summary (2018) (1)
- Reply to US lung cancer trends by histologic type (2015) (1)
- MA12.06 Tumor Spread through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis (2017) (1)
- PATHOLOGY INFORMATICS SUMMIT 2018 (2018) (1)
- Clinical, pathologic, and biochemical features of a cholesterol lipidosis accompanied by hyperlipidemia and xanthomas (1992) (1)
- MA12.10 Histological Subtyping of Matched Primary and Metastases Sites in Lung Adenocarcinoma: Significance of Solid Predominance (2017) (1)
- TNM Classificationof Malignant Mesothelioma of the Pleura (1999) (1)
- r ecommendations for the Management of s ubsolid Pulmonary n odules Detected at cT: A Statement from the (2013) (1)
- Navy Lung Disease Assessment Program (2004) (1)
- Pathology of drug-induced respiratory disease (2010) (1)
- MA 15.09 Circumferential Distribution and Distance from Main Tumor of Tumor Spread Through Air Spaces (STAS) Are Prognostic (2017) (1)
- MA09.06 The Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) is as Clinically Important as the Classical Pattern (2018) (1)
- Diagnosis of Hypersensitivity Pneumonitis: Review and Summary of American College of Chest Physicians Statement. (2021) (1)
- Vasculitides and Other Causes of Pulmonary Hemorrhage (2008) (1)
- PUB019 Preoperative Needle Biopsy and Tumor Spread through Alveolar Spaces (STAS) in Resected Lung Adenocarcinomas (2017) (1)
- P1.13-003 Recurrence Dynamics in Resected Pathological Stage I Lung Adenocarcinoma Depend on the IASLC/ATS/ERS Histological Subtype (2017) (1)
- Pathology of pulmonary granulomatous vasculitis. (1996) (1)
- High ERCC1 expression correlates with poor survival in lung adenocarcinoma: PD1-3-7 (2007) (1)
- Photodynamic therapy for surface malignancies: Clinical results and correlation with blood flow effects secondary to photoirradiation (1987) (1)
- Histologic Subtype of Early-Stage Lung Adenocarcinoma Predicts Failure Patterns in Patients Treated With Stereotactic Body Radiation Therapy (2016) (1)
- NCCN Lung Cancer Screening , Version 3 . 2018 Clinical Practice Guidelines in Oncology (2018) (1)
- Understanding Nonspecific Interstitial Pneumonia: The Need for a Diagnostic Gold Standard (2009) (1)
- Prospective molecular analysis of small cell lung cancer (SCLC) using next generation sequencing (NGS). (2015) (1)
- Clinical relevance and TNM implications of the new concept of minimally-invasive adenocarcinomas in situ with a lepidic pattern. (2013) (1)
- Association of germ-line single nucleotide polymorphisms (SNPs) with pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with resectable non-small cell lung cancers. (2013) (0)
- O-007ANATOMICAL RESECTIONS ARE SUPERIOR TO WEDGE FOR THE OVERALL SURVIVAL IN STAGE I TYPICAL CARCINOID PATIENTS (2017) (0)
- Mast cell disease (1993) (0)
- E-82. High-grade neuroendocrine (NE) tumors: What we know and important unanswered questions (2003) (0)
- Utility of 18F-FDG PET and CT to assess response to neoadjuvant chemotherapy. (2015) (0)
- Prognostic Impact of Ground-Glass Opacity/Lepidic Component in Pulmonary Adenocarcinoma: A Hazy Staging Dilemma. (2022) (0)
- PUB015 The Use of Immunohistochemistry Improves the Diagnosis of SCLC. An International Reproducibility Study in a Demanding Set of Cases (2017) (0)
- INFLAMMATORY DISORDERS : SPECTRUM, PATHOGENESIS, AND PATHOLOGY (1998) (0)
- Abstract CT112: AI-powered and manual assessment of PD-L1 are comparable in predicting response to neoadjuvant atezolizumab in patients (pts) with resectable non-squamous, non-small cell lung cancer (NSCLC) (2022) (0)
- P1.03-084 Implications of 8th Edition TNM Proposal: Invasive vs. Total Size for T Descriptor in pT1a-2bN0M0 Lung Adenocarcinoma: Topic: Staging (2017) (0)
- 14 – Pathology: Malignant and Interstitial Lung Diseases (2016) (0)
- Primary fibrosarcoma of lung: Clinicopathologic and immunohistochemical analysis of seven cases (1994) (0)
- COMMENT ON: LUNG CANCER AFTER HODGKIN'S DISEASE. AUTHORS'S REPLIES (1996) (0)
- The 2021 WHO Classi fi cation of Tumors of the Pleura: Advances Since the 2015 Classi fi cation (2022) (0)
- Prognostic significance of a diagnosis of multiple lung cancers. (2015) (0)
- Advances in Brief A Preliminary Transcriptome Map of Non-Small Cell Lung Cancer (2002) (0)
- Abstract 12: Characterizing KRAS G12C and other mutations in plasma ctDNA from patients with lung cancer (2020) (0)
- Large cell neuroendocrine carcinoma of the head and neck q (2012) (0)
- Amino Acid Sequence Composition of AA Amyloid Fibrils in Cystic Fibrosis (1988) (0)
- Genomic and transcriptomic analysis of a diffuse pleural mesothelioma patient-derived xenograft library (2022) (0)
- Definitions and Explanatory Notes (1999) (0)
- Minimally invasive adenocarcinoma (2015) (0)
- Micropapillary and Solid Histologic Patterns in N1 and N2 Lymph Node Metastases Are Independent Factors of Poor Prognosis in Patients with Stage II-III Lung Adenocarcinoma. (2023) (0)
- The wrong medicine for the disease (1974) (0)
- 11 – Pulmonary Vasculitis and Pulmonary Hemorrhage (2018) (0)
- Abstract 1208: Is the decrease in the incidence of large cell carcinoma of the lung due to changes in classification towards adenocarcinoma (2018) (0)
- NEOSCAN: Phase II trial of neoadjuvant chemotherapy for resectable lung cancers with switch to chemo alternative in 18F-FDG PET nonresponders. (2014) (0)
- 336 Identification of focal mast cell lesions in the bone marrow of children with mastocytosis (1988) (0)
- Lung Cancer Pathology Blueprint for Future Work (2007) (0)
- The New “Chest Imaging and Pathology for Clinicians” Section of CHEST (2006) (0)
- A Pathologic and Molecular Study of 8 Cases (2016) (0)
- Tumor Spread through Airspaces and Histologic Subtype Predict Outcomes Following Post-operative Radiation Therapy for Locally Advanced Lung Adenocarcinoma (2017) (0)
- Abstract 5895: Whole-genome characterization of lung adenocarcinomas lacking alterations in RTK/RAS/RAF/MAPK pathway (2020) (0)
- EGFR , KRAS , TTF-1 , p 63 , squamous cell carcinoma (2012) (0)
- USCAP 2018 Abstracts: Pulmonary Pathology (2011–2128) (2018) (0)
- Changing nomenclature of small cell carcinoma. Authors' reply (2003) (0)
- Primary pulmonary rhabdomyosarcoma of the lung in adults: A report of three cases (1994) (0)
- Abstract 1202: Expression signature for classification of non-small cell lung cancer. (2013) (0)
- Lung Cancer ScreeningPractice Guidelines in Oncology (2012) (0)
- Histologic Classification and Its Need for Treatment of Lung Cancer (2015) (0)
- Agreement Of Pathological Diagnosis In Fibrosing Interstitial Pneumonia (2010) (0)
- Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting. (2023) (0)
- Abstract 610: Prospective genomic characterization of small cell lung cancer by targeted next generation sequencing (2015) (0)
- Atypical pathogens presenting with pulmonary consolidations detected by cell-free DNA next-generation sequencing in patients with hematologic malignancies. (2022) (0)
- in Vivo α Lungs of Mice by Administration of Recombinant Interleukin 1 Decrease in Interleukin 2-induced Vascular Leakage in the (2013) (0)
- Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma. (2023) (0)
- AB009. OS02.03. Phase II trial of cetuximab and chemotherapy followed by surgical resection for locally advanced thymoma (2017) (0)
- HYPOS—Hourly System Hydropower Scheduling (1986) (0)
- MA 17.13 Impact of Histologic Subtype of Locally Advanced Lung Adenocarcinoma on Outcomes After Definitive Chemoradiation (2017) (0)
- MA12.08 Clinicopathological Significance of Increasing Percentage of High-Grade Histological Subtypes in Lung Adenocarcinomas (2017) (0)
- Initial Experience With Lung thereafter were deemed appropriate for lung cancer Cancer Resection After Treatment With T-Cell Checkpoint Inhibitors (2017) (0)
- FDG-PET Maximum Standardized Uptake Value and Histological Subtype Predict High Risk for Recurrence in Early-Stage Lung Adenocarcinoma Treated with Stereotactic Body Radiation Therapy (2017) (0)
- Next generation sequencing (NGS) in resectable non-small cell lung cancer (NSCLC): Therapeutic implications. (2016) (0)
- New M alignant D iseases A fter A llogeneic M arrow Transplantation f or C hildhood A cute L eukemia (2000) (0)
- Abstract A13: Lung Adenocarcinoma Subtypes Based on the Expression of Airway Basal Cell Genes (2012) (0)
- PUB018 Immunotherapy for KRAS Positive Lung Adenocarcinoma: Mesothelin and CA125 (MUC16) Are Cancer-Antigen Targets (2017) (0)
- P2.05-021 Occult Nodal Metastasis Following Lobectomy for Clinical Stage I Lung Adenocarcinoma: Implications for Sublobar Resection (2017) (0)
- Pulmonary Pathology Society Lifetime Achievement Award, 2007: Raymond Yesner, MD, professor of pathology emeritus, Yale University School of Medicine. (2007) (0)
- 528 The recognition of heterogeneity in mast cell disorders (1988) (0)
- ES12.05 Impact of STAS in Lung Cancer Staging (2019) (0)
- The impact of adjuvant chemotherapy in atypical carcinoid of the lung. A propensity score analysis of the European Society of Thoracic Surgeons lung neuroendocrine database (2015) (0)
- OA24.06 Histologic Subtype of Early-Stage Lung Adenocarcinoma is a Predictor of Failure Patterns after Stereotactic Body Radiation Therapy (2017) (0)
- Pleural Malignant Mesothelioma : Signi fi cant Advances Histologic Subtyping of Epithelioid Mesothelioma (2016) (0)
- PD-009 Desmoglein 3 as a prognostic indicator in lung cancer (2005) (0)
- The possibility of molecular targeted therapy in patients with pulmonary large cell neuroendocrine carcinoma. (2010) (0)
- Pulmonary papillomas Review of 16 cases with proposed revised classification (1997) (0)
- P38.04 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT (2021) (0)
- Non‐small cell lung carcinomas with diffuse coexpression of TTF1 and p40: clinicopathological and genomic features of 14 rare biphenotypic tumours (2022) (0)
- Spencer's Pathology of the Lung: The lungs in connective tissue disease (2013) (0)
- MA12.09 Comparative Histological Subtype Analysis of Lung Adenocarcinoma Tumor and Metastatic Lymph Nodes and the Prognostic Impact (2017) (0)
- Pathology of Adenocarcinoma (2014) (0)
- TABLE 1. TREATMENT ADMINISTERED TO 99 PATIENTS WITH IDIOPATHIC USUAL INTERSTITIAL PNEUMONIA AND 9 PATIENTS WITH COLLAGEN VASCULAR DISEASE-ASSOCIATED USUAL INTERSTITIAL PNEUMONIA (2003) (0)
- O-256 Prognostic significance Brm expression patterns in non-small cell lung cancer (NSCLC) (2003) (0)
- Clinical significance of the AKT pathway in small cell lung cancer and other neuroendocrine tumors: P1-181 (2007) (0)
- B-004PROGNOSTIC MODEL OF SURVIVAL FOR TYPICAL BRONCHIAL CARCINOID TUMOURS: ANALYSIS OF 1090 PATIENTS ON BEHALF OF THE ESTS NEUROENDOCRINE TUMOURS WORKING GROUP (2014) (0)
- 669 Neuroendocrine (NE) tumors of the lung: Prognostic factors in 152 cases (1997) (0)
- A Role for the Integrin a v b 8 in the Negative Regulation of Epithelial Cell Growth 1 (2000) (0)
- Clinical outcomes of immune checkpoint inhibitors in HER2-amplified non-small cell lung cancers. (2022) (0)
- Box 1 Histologic classification of lung cancera Preinvasive lesions (0)
- A lung adenocarcinoma subset associated with non-smokers, micropapillary architecture, distinct transcript profile, and EGFR mutation (2006) (0)
- TNM Classification of Lung Carcinoma (1999) (0)
- Reply: Characterization of lymphangioleiomyomatosis as a neoplastic disease. (2013) (0)
- E-pathology and mesothelioma : the experience of the international mesothelioma panel (2008) (0)
- Gene expession prolifing of large cell neuroendocrine carcinoma (LCNEC): PD1-3-6 (2007) (0)
- Quantitating pathologic response to neoadjuvant chemotherapy in KRAS-mutated versus nonmutated lung cancers. (2012) (0)
- Radiologic and histopathologic features of hydrogel sealant after lung resection in participants of a prospective randomized clinical trial. (2022) (0)
- OA 03.03 Phase II Trial of Cetuximab and Chemotherapy Followed by Surgical Resection for Locally Advanced Thymoma (2017) (0)
- Alleile Deletion Analysis of the FHIT Gene Predicts Poor Survival in Non-Small Cell Lung Cancer (2006) (0)
- MS10.04 Therapeutic Implications of Spread Through Air Spaces (STAS) (2018) (0)
- COP, GOP and AFOP in a Cancer Hospital. (2009) (0)
- MA01.02 Histologic Subtyping in Pathologic Stage I Lung Adenocarcinoma Provides Risk-Based Stratification for Surveillance (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With William D. Travis?
William D. Travis is affiliated with the following schools:
